Ambrosia Launches India’s First 24x7 Real-Time Glucose & Stress Monitor

This innovative service integrates wearable sensor technology, AI-powered analytics, and remote monitoring, providing continuous health insights to individuals.

Ambrosia, a global leader in real-time health monitoring, has introduced India’s first 24x7 real-time glucose and stress monitoring service following its successful adoption in the United States and Europe.

This innovative service integrates wearable sensor technology, AI-powered analytics, and remote monitoring, providing continuous health insights to individuals.

India has over 100 million people affected by diabetes, alongside millions experiencing chronic stress-related disorders. Traditional glucose monitoring methods rely on intermittent testing, leaving critical gaps in data.

Ambrosia says its glucose and stress monitoring service addresses this issue with real-time monitoring technology, offering AI-driven alerts and personalized health insights to improve diabetes and stress management.

Ambrosia’s AI-Packed Features

Ambrosia’s solution includes unique features such as food insights, which help users assess meal impacts on glucose levels, Dia-Buddy, an AI companion for smarter diabetes management, and customizable alarms that notify users and caregivers about critical glucose levels.

The service also enhances safety for children with diabetes, allowing parents to remotely monitor glucose fluctuations and ensure timely interventions.

The A-CGM (Real-time CGM) and A-Ring (Smart Ring) integrate seamlessly with the LinkBluCon mobile and smartwatch app, offering real-time data and AI-powered insights.

This service is designed to cater to diverse users, including individuals with diabetes, prediabetes, fitness enthusiasts, busy professionals, and parents requiring remote monitoring for their children.

India's Continuous Glucose Monitoring (CGM) landscape is evolving rapidly, driven by the rising prevalence of diabetes and advancements in wearable health technology. Last year, Beurer India, a subsidiary of German healthcare leader Beurer GmbH, introduced the GL 22 Blood Glucose Monitor, aimed at improving diabetes management in the country. Manufactured under Beurer’s ‘Make in India’ initiative, the device features advanced monitoring capabilities tailored to the needs of Indian users.

Stay tuned for more such updates on Digital Health News.